Member event: The Life Sciences Paradox debates investment in innovation

Innovation is crucial, yet regulatory restrictions, slow market adoption, budget cuts and increased competition are putting immense pressure on medical companies’ investment choices. Will you stay focused on current product lines and technologies? Or will you put more emphasis on solving longer-term challenges in preventative, personalized and value-based healthcare?

These are the questions at the heart of The Life Sciences Paradox, a free morning seminar on 22 September. Co-hosted by MEDVIA members Verhaert Masters, Cochlear and imec, as well as Dutch organization MedtechPartners, the seminar is free and can be attended virtually or in person at Verhaert in Kruibeke, East Flanders.

Four sessions will cover different facets of the issue. MedtechPartners will begin with ‘The reimbursement paradox’, followed by imec’s R&D paradox, Verhaert’s digital paradox and Cochlear’s user insights paradox.

Join the conversation to learn about the pathway from innovative digital care to reimbursed healthcare, whether to base innovation on technology push or market pull, digitizing your company’s processes or products and how to choose between user experience and clinical trials in digitizing new products.